PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Can anti-depressants help prevent Alzheimer's disease?

Penn researcher studies effects of common anti-depressant on brain peptide thought to be responsible for the development of Alzheimer's

Can anti-depressants help prevent Alzheimer's disease?
2014-05-14
(Press-News.org) PHILADELPHIA – A University of Pennsylvania researcher has discovered that the common selective serotonin reuptake inhibitor (SSRI) citalopram arrested the growth of amyloid beta, a peptide in the brain that clusters in plaques that are thought to trigger the development of Alzheimer's disease (AD). Penn, in collaboration with investigators at Washington University, tested the drug's effects on the brain interstitial fluid (ISF) in plaque-bearing mice and the cerebrospinal fluid (CSF) of healthy human subjects to draw its conclusions, which are detailed in the new issue of Science Translational Medicine.

Alzheimer's disease is the sixth leading cause of death the United States, affecting five million patients, with the numbers expected to leap to approximately 16 million patients in the coming decades, unless preventive measures are developed.

"Our previous studies have shown an association between anti-depressants and the reduction in amyloid burden in the brain," says the paper's lead author, Yvette Sheline, MD, professor of Psychiatry, Radiology and Neurology and director of the Center for Neuromodulation in Depression and Stress, at Penn's Perelman School of Medicine. "Those studies examined a retrospective correlation between the duration of anti-depressant use and amyloid burden shown in PET scans in the brains of elderly volunteers. With this new study we took our research a step further and tested the prospective effect of the SSRI citalopram on the CSF amyloid levels in younger, healthy subjects." Sheline performed the research while at Washington University.

She again found that citalopram, which is approved by the FDA in 1998 for the treatment of depression, had significant effects.

The brain interstitial fluid (ISF) of transgenic plaque-bearing mice following exposure to citalopram showed that the level of amyloid-beta in the ISF decreased in a dose-dependent manner by as much as 25 percent compared to baseline numbers. In addition, the researchers found that two months of citalopram exposure in plaque-bearing mice resulted in no new plaque development, and no growth of existing plaques compared with a marked increase in plaque growth and development in the control group of mice, who were exposed to sugar water. However, citalopram had little effect on the regression of already existing amyloid plaques.

In a parallel study, 23 healthy human subjects, age 18 to 50 without medical disease and with no previous history of anti-depressant treatment, were administered 60 mg citalopram, roughly equivalent to the dose used in mice.

The double-blind study showed that citalopram was associated with a 38 percent lower A-beta concentration over the 37-hour testing period versus placebo, and showed a reduction in newly-produced A-beta in the citalopram-treated group versus the control group.

SSRIs are thought to produce their antidepressant effect by blocking the reuptake of the neurotransmitter serotonin into the presynaptic terminals of the neurons, increasing the availability of serotonin and reducing A-beta production. Serotonin receptor levels are reduced in brains of patients with AD. In contrast, this newly described effect on the reduction of amyloid protein concentration most likely occurs by a different pathway.

The development of safe and effective therapeutic approaches that can reduce CSF A-beta production even modestly may prevent a cascade of neuronal damage, which would have an important impact on preventing or slowing progression to symptomatic AD.

"While these results are an excellent start at lowering A-beta production, we are a long way from making a statement regarding the ability of SSRIs to prevent the cognitive decline associated with AD," Sheline says. "We are developing a greater understanding of the capabilities of SSRIs, which offer promise for the future as preventive measures, as we continue to uncover the complex mechanisms in the brain that trigger Alzheimer's and dementia."

INFORMATION:

Funding for this research was provided by NIH grants R21 AG03969002, R01 AG04140202, R01 AG042513, R21 NS082529, R01 NS067905, Washington University Hope Center for Neurological Diseases and Washington University Biomedical Mass Spectrometry Resource.

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $392 million awarded in the 2013 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; Chester County Hospital; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2013, Penn Medicine provided $814 million to benefit our community.

[Attachments] See images for this press release:
Can anti-depressants help prevent Alzheimer's disease?

ELSE PRESS RELEASES FROM THIS DATE:

Hitting a moving target

Hitting a moving target
2014-05-14
LA JOLLA, CA—May 14, 2014—A vaccine or other therapy directed at a single site on a surface protein of HIV could in principle neutralize nearly all strains of the virus—thanks to the diversity of targets the site presents to the human immune system. The finding, from a study led by scientists at The Scripps Research Institute (TSRI), is likely to influence future designs for HIV vaccines and antibody-based therapies. "We found, for example, that if the virus tries to escape from an antibody directed at that site by eliminating one of its sugars, the antibody often ...

Deformable mirror corrects errors

Deformable mirror corrects errors
2014-05-14
This news release is available in German. Lasers are used in manufacturing to cut materials or weld components together. Laser light is focused to a point using various lenses and mirrors; the smaller the focal point and the higher the energy, the more accurately operators can work with the laser. So, turn up the power and off you go, right? It is not that simple because when laser power increases, the mirror heats up accordingly, causing it to deform. A deformed mirror cannot effectively focus the laser; the focal point gets bigger and laser power falls away. Precisely ...

Victims want to change, not just punish, offenders

2014-05-14
Revenge is a dish best served with a side of change. A series of experiments conducted by researchers affiliated with Princeton University has found that punishment is only satisfying to victims if the offenders change their attitude as a result of the punishment. "Revenge is only 'sweet' if the person reacts with a change in attitude, if the person understands that what they did was wrong. It is not the act itself that makes punishment satisfying," said Friederike Funk, a Princeton graduate student in psychology and one of the researchers. The findings offer insights ...

Study shows breastfeeding, birth control may reduce ovarian cancer risk in women with BRCA mutations

2014-05-14
PHILADELPHIA — Breastfeeding, tubal ligation – also known as having one's "tubes tied" – and oral contraceptives may lower the risk of ovarian cancer for some women with BRCA gene mutations, according to a comprehensive analysis from a team at the University of Pennsylvania's Basser Research Center for BRCA and the Abramson Cancer Center. The findings, a meta-analysis of 44 existing peer-reviewed studies, are published in the Journal of the National Cancer Institute. The researchers, from Penn's Perelman School of Medicine, found that breastfeeding and tubal ligation ...

New insight into thermoelectric materials may boost green technologies

New insight into thermoelectric materials may boost green technologies
2014-05-14
Coral Gables, Fla. (May 15, 2014) — Thermoelectric materials can turn a temperature difference into an electric voltage. Among their uses in a variety of specialized applications: generating power on space probes and cooling seats in fancy cars. University of Miami (UM) physicist Joshua Cohn and his collaborators report new surprising properties of a metal named lithium purple-bronze (LiPB) that may impact the search for materials useful in power generation, refrigeration, or energy detection. The findings are published in the journal Physical Review Letters. "If current ...

SapC-DOPS technology may help with imaging brain tumors, research shows

2014-05-14
Just because you can't see something doesn't mean it's not there. Brain tumors are an extremely serious example of this and are not only difficult to treat—both adult and pediatric patients have a five-year survival rate of only 30 percent—but also have even been difficult to image, which could provide important information for deciding next steps in the treatment process. However, Cincinnati Cancer Center and University of Cincinnati Cancer Institute research studies published in an April online issue of the Journal of Magnetic Resonance Imaging and a May issue of ...

How cone snail venom minimizes pain

How cone snail venom minimizes pain
2014-05-14
The venom from marine cone snails, used to immobilize prey, contains numerous peptides called conotoxins, some of which can act as painkillers in mammals. A recent study in The Journal of General Physiology provides new insight into the mechanisms by which one conotoxin, Vc1.1, inhibits pain. The findings help explain the analgesic powers of this naturally occurring toxin and could eventually lead to the development of synthetic forms of Vc1.1 to treat certain types of neuropathic pain in humans. Neuropathic pain, a form of chronic pain that occurs in conjunction with ...

Scientists test hearing in Bristol Bay beluga whale population

Scientists test hearing in Bristol Bay beluga whale population
2014-05-14
The ocean is an increasingly industrialized space. Shipping, fishing, and recreational vessels, oil and gas exploration and other human activities all increase noise levels in the ocean and make it more difficult for marine mammals to hear and potentially diminish their range of hearing. "Hearing is the main way marine mammals find their way around the ocean," said Aran Mooney, a biologist at Woods Hole Oceanographic Institution (WHOI). It's important to know whether and to what extent human activity is negatively impacting them. But how can we get marine mammals living ...

Snubbing lion hunters could preserve the endangered animals

2014-05-14
For hundreds of years young men from some ethnic groups in Tanzania, called "lion dancers" because they elaborately acted out their lion killing for spectators, were richly rewarded for killing lions that preyed on livestock and people. Now when a lion dancer shows up he might be called a rude name rather than receive a reward, according to a new UC Davis study. Some villagers are snubbing the lion killers, calling them "fakers" and contemplating punishing them and those who continue to reward them, said Monique Borgerhoff Mulder, anthropology professor at UC Davis. ...

Deconstructing goal-oriented movement

Deconstructing goal-oriented movement
2014-05-14
Our human brains are filled with maps: visual maps of our external environments, and motor maps that define how we interact physically within those environments. Somehow these separate points of reference need to correspond with — and to — one another in order for us to act, whether it's grasping a coffee cup or hitting a tennis ball. How that happens is the focus of a new study by scientists at UC Santa Barbara. The researchers used neuroimaging to decode how the brain transforms sensory input into action. Their findings are reported in the Journal of Neuroscience. ...

LAST 30 PRESS RELEASES:

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet

Balance between two competing nerve proteins deters symptoms of autism in mice

Use of antifungals in agriculture may increase resistance in an infectious yeast

Awareness grows of cancer risk from alcohol consumption, survey finds

The experts that can outsmart optical illusions

Pregnancy may reduce long COVID risk

Scientists uncover novel immune mechanism in wheat tandem kinase

Three University of Virginia Engineering faculty elected as AAAS Fellows

Unintentional drug overdoses take a toll across the U.S. unequally, study finds

A step toward plant-based gelatin

ECMWF unveils groundbreaking ML tool for enhanced fire prediction

[Press-News.org] Can anti-depressants help prevent Alzheimer's disease?
Penn researcher studies effects of common anti-depressant on brain peptide thought to be responsible for the development of Alzheimer's